Business article - August 26, 2024
Attana’s technology applied in malaria vaccine development
In a new publication in “Vaccines” from Department of Immunology and Microbiology, Centre for translational Medicine & Parasitology at Copenhagen University, Attana’s technology has been applied to determine the interaction kinetics between antibodies from vaccinated mice and the pathogen antigen used for the vaccines. This provides valuable information for creating a vaccine with optimal neutralizing […]
Pharma Diagnostics - August 9, 2024
Alzheimer’s blood test proves highly effective in primary healthcare
A commercially available blood test has now been trialled in routine healthcare. “The blood test showed about 90% reliability even in primary care. This may have major implications for all those individuals who seek help for memory loss and suspected Alzheimer’s,” say the researchers at Lund University in Sweden behind the study. The current study, […]
Financing - June 10, 2024
Qlucore receives EU grant to advance personalized cancer treatment
Qlucore will receive an EIC Accelerator grant of EUR 2.5 million to accelerate the development of clinical cancer diagnostics solutions for acute myeloid leukemia (AML) as well as bladder cancer. In March the grant was made public and Qlucore is now starting the project and has received the first payment. The project will stretch over […]
Financing - April 29, 2024
AI Medical Technology raises USD 1 million
The company has announced the successful closure of an oversubscribed bridge financing round. Funding was provided by existing investors, such as Northern Venture CapSek, and new shareholders. The money will be used to support ongoing regulatory efforts and development of the company’s AI-driven support tool, Dermalyser, a clinically validated decision support tool for the diagnosis […]
Clinical Trials - April 8, 2024
Elypta presents interim study results
Elypta has announced that the interim results from the LEVANTIS-0087A study will be presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting in San Diego during the Biomarker-Based Screening session on April 9. The population-based case-control study included 2,054 adults over the age of 18 with no symptoms of cancer from the […]
Pharma Business - November 11, 2022
Devyser establishes CLIA lab in Atlanta
Devyser announces its decision to establish a CLIA lab in Atlanta, Georgia, USA. By operating a CLIA lab, Devyser obtains complete control of the selling process, including reimbursement management, ensuring value-based pricing and improved margins. It also allows for closer interaction with physicians and patients. The company aims to have the lab CLIA certified and […]
